Register
Login:
Share:
Email Facebook Twitter


EXCLUSIVE: Alastair Smith, Avacta Group CEO gives an Operational Update


Flying Brand Share Price (FBDU)



Share Price Information for Flying Brand (FBDU)


Share Price: 2.10Bid: 2.00Ask: 2.20Change: 0.00 (0.00%)No Movement on Flying Brand
Spread: 0.20Spread as %: 10.00%Open: 2.10High: 2.10Low: 2.10Yesterday’s Close: 2.10

Flying Brands Ld Ord Gbp0.01

Flying Brand is part of the Retailers sector






Share Price SpacerPrice
2.10
Share Price SpacerBid
2.00
Share Price SpacerAsk
2.20
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
45,000
Share Price SpacerOpen
2.10
Share Price SpacerHigh
2.10
Share Price SpacerLow
2.10
Share Price SpacerClose
2.10
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 120.35m £2.53m 30,000

52 Week High 5.45 52 Week High Date 8-FEB-2018
52 Week Low 1.80 52 Week Low Date 29-AUG-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
1 0 45,000 -3.750 -0.56 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

21-Sep-18
08:01:48
2.1499
45,000
Buy* 
2.00
2.20
967.46
Trade Type:
Ordinary

20-Sep-18
11:15:54
2.16
23,703
Buy* 
2.00
2.20
511.98
Trade Type:
Ordinary

20-Sep-18
11:15:32
2.0500
99,532
Sell* 
2.00
2.20
2,040
Trade Type:
Ordinary




View more Flying Brand trades >>

Directors Deals for Flying Brand (FBDU)
Trade DateActionNotifierPriceCurrencyAmountHolding
10-Sep-18Buy
Trade Notifier Information for Flying Brands Ltd
David W.J Smith held the position of COO at Flying Brands Ltd at the time of this trade.
 David W.J Smith
2.48GBX1,000,0001000000
21-Apr-10Buy
Trade Notifier Information for Flying Brands
Stephen Cook held the position of Group Chief Executive at Flying Brands at the time of this trade.
 Stephen Cook
57GBX35,0003195000
20-Apr-10Buy
Trade Notifier Information for Flying Brands
John Henwood held the position of Non-Executive Director at Flying Brands at the time of this trade.
 John Henwood
56GBX30,00040000
View more Flying Brand directors dealings >>


Elartu
Posts: 1,505
Opinion:No Opinion
Price:2.10
RE: Elartu
Thu 13:35
Hi Dragon,
Your post helps considerably. Thank you very much for explaining the FDA process. Ironically, it looks as though Stone Checker getting FDA product approval is likely to benefit Feedback when they get around to running their TexRAD Lung product through the FDA process.
dragon10
Posts: 249
Opinion:No Opinion
Price:2.10
RE: Elartu
Thu 12:43
Hi Elartu,
I follow the company closely, and also don't think there'll be a problem with fda approval.
On your point about approval and the TexRAD software employed within the stonechecker product, it would definitely be easier if this software had previously been used within a product, but all fda submissions are product specific so this is not a necessity and would only have helped by making the process smoother.
I work within diagnostics and we have a technology which is used on tests, and this undergoes a new fda submission for each product it goes into. It obviously helps that we've been through the process previously, but each product is treated differently and assessed thoroughly as it's own product.
510k submissions are slightly different in that they are assessing against a predicate, which makes the process easier again.
Not sure if this helps but these are the reasons I don't see that as an issue
Elartu
Posts: 1,505
Opinion:No Opinion
Price:2.10
RE: Elartu
Thu 10:47
Good morning Shan & Draft,

Draft, as per your post, I am not forgetting Imaging Biometrics, it's just that I am not that interested in them as my main focus is on TexRAD at present. However, if you could supply me with IB's income and expenditure figures over the past 2-3 years I will endeavour to take a closer look.

Shan, I am currently only invested in Feedback. I have trust issues with one of the board members of Flying Brands which is why I was asking the posters here as to how they were expecting to get FDA approval for the Stone Checker product when the TexRAD software analytics that is core to its usage has not yet gone through the FDA approval process.

You all seem quite happy that this isn't going to be a problem but didn't elucidate as to why that was the case other than the company was working closely with the FDA. I decided not to push the matter further.

I note however Shan that you seem to think Feedback need more money (almost certainly correct) whereas Flying Brands are 'fully funded' (almost certainly incorrect). I will attempt to demonstrate why I believe you are incorrect regarding Flying Brands.

In the company's half year report the cash position as at 30th June was £5,000.

The company then raised via a placing in mid-July a sum of £500,000 to keep the lights on.

This exercise cost the company £84,000 leaving FBDU with a sum of £416,000.

It planned to spend the money as follows:

A PACS compliant software plug in for Stone Checker - £80,463.
Imaging Biometrics – cash for operational expenses - £60,000.
FDA fees for Stone Checker - £48,161.
COO's wages - £110,000.
Payment of other wages, legal fees, accountancy fees, UKLA and LSE fees, printing costs, consultancy fees, Stone Checker software trials, developing improved products - £200,000.

That's a total planned expenditure of £498,624.

Now here's the crux for me. In the last 6 months the company lost before tax £371,000. That's a loss of £61,833 per month.

So, with £416,000 raised that might keep the lights on another 6-7 months or just under 6 months if you add in the new COO's wages.

Look at what they raised, and look at the proposed expenditure. How much of it benefits and pushes the company forward and how much of it benefits the people within the company?

So, FBDU had next to no cash at the end of June and the £416,000 they received from the placing will likely last them around 6 months. Shan, I don't view this company as 'fully funded' like you say. In fact, unless Draft can show me immediate exceptional profits arising from IB, I would anticipate your board going back to the market for more cash around Christmas / New Year.
draft
Posts: 14,789
Opinion:No Opinion
Price:2.10
RE: Elartu
Thu 07:00
The wood from the trees is your totally forgetting Imaging Biometrics, already FDA approved, and already making sales and signing top strategic partners like Qmenta and ECOG for the cancer trials.
shan90
Posts: 319
Opinion:No Opinion
Price:2.10
RE: Elartu
Thu 00:10
Elartu are u invested in fbdu or just fdbk? Fdbk need money btw.. fbdu is fully funded
View more share chat for Flying Brand (FBDU) >>




Flying Brands Ld Ord Gbp0.01 home pageWebsite: Flying Brands Ld Ord Gbp0.01
Website Description: Flying Brands



Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.